Mindful Innovation
Mastering Challenges. Compassion for Patients. Transforming Medicine.
At Marinus Pharmaceuticals, our passionate team of experts is constantly innovating with the aim to drastically improve lives affected by rare epilepsies and neuropsychiatric disorders.
Commitment
Improving lives of patients suffering from seizures and neuropsychiatric disorders
We are laser focused on treating patients with severe, rare forms of epilepsy, implementing a clinical trial strategy that is guided by our strong scientific rationale, and unlocking the potential of ganaxolone across a range of CNS disorders.
— Scott Braunstein, M.D., CEO, Marinus Pharmaceuticals
-
Ganaxolone
Dedicated to the development of ganaxolone
We are dedicated to maximizing the value of ganaxolone as a first-in-class innovative neuropsychiatric therapy with a portfolio of diversified indications.
-
Pipeline
Discover the science behind ganaxolone
Ganaxolone, through its validated GABAA mechanism, has opportunities in orphan indications and in chronic and acute care settings.
-
Focus Areas
Focused on rare seizure and neuropsychiatric disorders
We are developing breakthrough therapies in status epilepticus, tuberous sclerosis complex, PCDH19-related epilepsy, and CDKL5 deficiency disorder.
-
Trials
Our goal is developing safe and effective treatments
We are conducting high quality research in-house, with our scientific advisory board and external consultants to ensure patients are receiving innovative and safe treatment options.
Providing a range of clinical trials to develop innovative treatments for patients

Status Epilepticus
Striving to maintain seizure control
Developing therapies with the potential to provide rapid cessation of status epilepticus and prevent escalation of treatment
CDLK5 deficiency disorder
Aspiring to give children significantly less seizures and better quality of life
Ganaxolone offers the potential to safely decrease seizure frequency in children with refractory epilepsy
Advocacy
Fostering a community for those impacted by rare diseases
Collaborating with key groups to support patients and their families, working to lessen the burden of rare diseases and disorders

Want to make an impact?
We are always looking for dedicated and passionate professionals who want to make a positive difference in the lives of those affected by rare epilepsies and neuropsychiatric disorders.